Previous 10 | Next 10 |
home / stock / dxcm / dxcm articles
U.S. stock futures were higher this morning, with the Nasdaq futures gaining over 150 points on Friday. Shares of Intel Corporation (NASDAQ:INTC) s...
DexCom (NASDAQ:DXCM) has outperformed the market over the past 5 years by 23.93% on an annualized basis producing an average annual return of 35.38...
The Nasdaq 100 closed lower by around 0.1% on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it...
On CNBC’s "Halftime Report Final Trades," Jenny Harrington of Gilman Hill Asset Management named SL Green Realty Corp. (NYS...
Tuesday, the FDA approved DexCom Inc’s (NASDAQ:DXCM) Stelo Glucose Biosensor System as the first over-the-counter (OTC) contin...
Tuesday, the FDA approved DexCom Inc’s (NASDAQ:DXCM) Stelo Glucose Biosensor System as the first over-the-counter (OTC) contin...
With U.S. stock futures trading mostly higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: Wall...
Thursday, after-hours Dexcom Inc (NASDAQ:DXCM) reported fourth-quarter 2023 earnings with sales of $1.03 billion, up 27% Y/Y (+26% on an ...
DexCom (NASDAQ:DXCM) has outperformed the market over the past 15 years by 26.47% on an annualized basis producing an average annual return of 39.0...
News, Short Squeeze, Breakout and More Instantly...
2024-07-04 10:00:00 ET Growth-oriented investors have experienced a bit of a roller-coaster ride over the past few years. Many companies in the "growth stock" category were struggling just two years ago, but in the bull market we are now experiencing, they're delivering very different resul...
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2024 financial results after market close on Thursday, July 25, 2024. Management will hold a conference call to review the company's second quarter 2024 performance starting at 4:30 p.m. (Eastern Time) on the...